Marcel Schilling

Mr. Marcel Schilling

Genetics, Microbiology and Statistics, Universitat de Barcelona, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Cell
Verified
Journal Article
Closed access
SHSebastiaan van Heesch
Sebastiaan van Heesch
FWFranziska Witte
Franziska Witte
VSValentin Schneider-Lunitz
Valentin Schneider-Lunitz
JSJana F. Schulz
Jana F. Schulz
EAEleonora Adami
Eleonora Adami
NHNorbert Hubner
Norbert Hubner

15 March 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CLChristina M. Lill
Christina M. Lill
JRJohannes T. Roehr
Johannes T. Roehr
MMMatthew B. McQueen
Matthew B. McQueen
FKFotini K. Kavvoura
Fotini K. Kavvoura
SBSachin Bagade
Sachin Bagade
LBLars Bertram
Lars Bertram
More than 800 published genetic association studies have implicated dozens of potential risk loci in Parkinson's disease (PD). To facilitate the interpretation of these findings, we have created a dedicated online resource, PDGene, that comprehensively collects and meta-analyzes all published studies in the field. A systematic literature screen of ∼27,000 articles yielded 828 eligible articles from which relevant data were extracted. In addition, individual-level data from three publicly available genome-wide association studies (GWAS) were obtained and subjected to genotype imputation and analysis. Overall, we performed meta-analyses on more than seven million polymorphisms originating either from GWAS datasets and/or from smaller scale PD association studies. Meta-analyses on 147 SNPs were supplemented by unpublished GWAS data from up to 16,452 PD cases and 48,810 controls. Eleven loci showed genome-wide significant (P<5×10−8) association with disease risk: BST1, CCDC62/HIP1R, DGKQ/GAK, GBA, LRRK2, MAPT, MCCC1/LAMP3, PARK16, SNCA, STK39, and SYT11/RAB25. In addition, we identified novel evidence for genome-wide significant association with a polymorphism in ITGA8 (rs7077361, OR 0.88, P = 1.3×10−8). All meta-analysis results are freely available on a dedicated online database (www.pdgene.org), which is cross-linked with a customized track on the UCSC Genome Browser. Our study provides an exhaustive and up-to-date summary of the status of PD genetics research that can be readily scaled to include the results of future large-scale genetics projects, including next-generation sequencing studies. The genetic basis of Parkinson's disease is complex, i.e. it is determined by a number of different disease-causing and disease-predisposing genes. Especially the latter have proven difficult to find, evidenced by more than 800 published genetic association studies, typically showing discrepant results. To facilitate the interpretation of this large and continuously increasing body of data, we have created a freely available online database (“PDGene”: http://www.pdgene.org) which provides an exhaustive account of all published genetic association studies in PD. One particularly useful feature is the calculation and display of up-to-date summary statistics of published data for overlapping DNA sequence variants (polymorphisms). These meta-analyses revealed eleven gene loci that showed a statistically very significant (P<5×10−8; a.k.a. genome-wide significance) association with risk for PD: BST1, CCDC62/HIP1R, DGKQ/GAK, GBA, LRRK2, MAPT, MCCC1/LAMP3, PARK16, SNCA, STK39, SYT11/RAB25. In addition and purely by data-mining, we identified one novel PD susceptibility locus in a gene called ITGA8 (rs7077361, P = 1.3×10−8). We note that our continuously updated database represents the most comprehensive research synopsis of genetic association studies in PD to date. In addition to vastly facilitating the work of other PD geneticists, our approach may serve as a valuable example for other complex diseases.

1 June 2014 in Molecular Cell
Verified
Journal Article
Closed access
SGStefanie Grosswendt
Stefanie Grosswendt
AFAndrei Filipchyk
Andrei Filipchyk
MMMark Manzano
Mark Manzano
FKFilippos Klironomos
Filippos Klironomos
Marcel SchillingMarcel Schilling
Marcel Schilling
NRNikolaus Rajewsky
Nikolaus Rajewsky

21 April 2023 in Science Advances
Verified
Journal Article
Open access
LZLan-Ting Zhou
Lan-Ting Zhou
DLDan Liu
Dan Liu
HKHuicong Kang
Huicong Kang
LLLu Lu
Lu Lu
HHHe-Zhou Huang
He-Zhou Huang
LZLing-Qiang Zhu
Ling-Qiang Zhu
The neuron-glia cross-talk is critical to brain homeostasis and is particularly affected by neurodegenerative diseases. How neurons manipulate the neuron-astrocyte interaction under pathological conditions, such as hyperphosphorylated tau, a pathological hallmark in Alzheimer’s disease (AD), remains elusive. In this study, we identified excessively elevated neuronal expression of adenosine receptor 1 (Adora1 or A1R) in 3×Tg mice, MAPT P301L (rTg4510) mice, patients with AD, and patient-derived neurons. The up-regulation of A1R was found to be tau pathology dependent and posttranscriptionally regulated by Mef2c via miR-133a-3p. Rebuilding the miR-133a-3p/A1R signal effectively rescued synaptic and memory impairments in AD mice. Furthermore, neuronal A1R promoted the release of lipocalin 2 (Lcn2) and resulted in astrocyte activation. Last, silencing neuronal Lcn2 in AD mice ameliorated astrocyte activation and restored synaptic plasticity and learning/memory. Our findings reveal that the tau pathology remodels neuron-glial cross-talk and promotes neurodegenerative progression. Approaches targeting A1R and modulating this signaling pathway might be a potential therapeutic strategy for AD.

1 December 2018 in Developmental Cell
Verified
Journal Article
Closed access
ADAsija Diag
Asija Diag
Marcel SchillingMarcel Schilling
Marcel Schilling
FKFilippos Klironomos
Filippos Klironomos
SASalah Ayoub
Salah Ayoub
NRNikolaus Rajewsky
Nikolaus Rajewsky

1 June 2013 in Brain
Verified
Journal Article
Open access
PDF file
ICInternational Multiple Sclerosis Genetics Consortium
International Multiple Sclerosis Genetics Consortium
CLChristina M. Lill
Christina M. Lill
BSBrit-Maren M. Schjeide
Brit-Maren M. Schjeide
CGChristiane Graetz
Christiane Graetz
MBMaria Ban
Maria Ban
FZFrauke Zipp
Frauke Zipp
A recent genome-wide association study reported five loci for which there was strong, but sub-genome-wide significant evidence for association with multiple sclerosis risk. The aim of this study was to evaluate the role of these potential risk loci in a large and independent data set of ∼20 000 subjects. We tested five single nucleotide polymorphisms rs228614 (MANBA), rs630923 (CXCR5), rs2744148 (SOX8), rs180515 (RPS6KB1), and rs6062314 (ZBTB46) for association with multiple sclerosis risk in a total of 8499 cases with multiple sclerosis, 8765 unrelated control subjects and 958 trios of European descent. In addition, we assessed the overall evidence for association by combining these newly generated data with the results from the original genome-wide association study by meta-analysis. All five tested single nucleotide polymorphisms showed consistent and statistically significant evidence for association with multiple sclerosis in our validation data sets (rs228614: odds ratio = 0.91, P = 2.4 × 10−6; rs630923: odds ratio = 0.89, P = 1.2 × 10−4; rs2744148: odds ratio = 1.14, P = 1.8 × 10−6; rs180515: odds ratio = 1.12, P = 5.2 × 10−7; rs6062314: odds ratio = 0.90, P = 4.3 × 10−3). Combining our data with results from the previous genome-wide association study by meta-analysis, the evidence for association was strengthened further, surpassing the threshold for genome-wide significance (P < 5 × 10−8) in each case. Our study provides compelling evidence that these five loci are genuine multiple sclerosis susceptibility loci. These results may eventually lead to a better understanding of the underlying disease pathophysiology.